Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
?
Drug:  BCG vaccine
Find trials that include:  Any drugs shown
Trial Status:  Closed
Results 1-25 of 235 for your search:
Start Over
Phase II Chemotherapy with MTX/CF, Aminopterin or M-BACOD plus CTX or BCG Immunotherapy for Advanced non-Hodgkin's Lymphoma
Phase: Phase III, Phase II
Type: Treatment
Status: Closed
Age: 25 to 65
Sponsor:
Protocol IDs: DFCI-75116
Phase II-III Chemotherapy with ADR/VCR/ARA-C plus Immunotherapy with BCG and Irradiated Cells for Acute Myelogenous Leukemia
Phase: Phase III, Phase II
Type: Treatment
Status: Closed
Age: under 60
Sponsor:
Protocol IDs: EORTC-LAM-4
Phase III Study of Oral Bropirimine vs Intravesical BCG for BCG-Naive Carcinoma in Situ of the Bladder (Summary Last Modified 11/95)
Phase: Phase III
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: GBMC-M/1600/0015, UPJOHN-M/1600/0015, NCI-V95-0656
Surgery and BCG in Treating Patients With Bladder Cancer
Phase: Phase III
Type: Treatment
Status: Completed
Age: 85 and under
Sponsor: Other
Protocol IDs: EORTC-30962, NCT00002990
Vaccination Therapy in Treating Patients With Limited-Stage Small Cell Lung Cancer
Phase: Phase III
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Other
Protocol IDs: EORTC-08971, UCLA-9902001, NCT00003279
Phase III Randomized Study of Immunotherapy With Polyvalent Melanoma Vaccine (Canvaxin™) Plus BCG Versus BCG Plus Placebo After Surgery in Patients With Stage IV Melanoma
Phase: Phase III
Type: Treatment
Status: Completed
Age: 18 to 80
Sponsor: NCI
Protocol IDs: JWCI-MC-4-001, CV-MMAIT-4-001, RPCI-DS-98-16, NCI-G98-1492, NCT00052156
Biological Therapy in Treating Patients With Bladder Cancer
Phase: Phase III
Type: Treatment
Status: Completed
Age: 18 to 90
Sponsor: Other
Protocol IDs: SAKK 06/98, SWS-SAKK-06/98, EU-98075, NCT00003779
Phase III Randomized Study of BCG Plus a Polyvalent Melanoma Vaccine (Canvaxin™) Versus BCG Plus Placebo in Patients With Resected Stage III Melanoma
Phase: Phase III
Type: Treatment
Status: Completed
Age: 18 to 80
Sponsor: NCI
Protocol IDs: JWCI-MC-3-001A, CV-MMAIT-3-001, NCI-V99-1576, NCT00052130
Monoclonal Antibody Therapy Plus BCG in Treating Patients With Limited-Stage Small Cell Lung Cancer
Phase: Phase III
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Other
Protocol IDs: EORTC-08971B, NCT00006352
Phase III Therapy with DNM, ARA-C, AZC, Beta-TGDR, TG & BCG for Induction, Consolidation & Maintenance of Acute Myelogenous Leukemia (Summary Last Modified 04/97)
Phase: Phase III
Type: Treatment
Status: Completed
Age: 15 and over
Sponsor:
Protocol IDs: SEG-77AML318, SEG-77AML0103
Phase III Chemotherapy with VCR/ARA-C/PRED vs VCR/ARA-C/PRED plus BCG Immunotherapy for Adult Acute Leukemia
Phase: Phase III
Type: Treatment
Status: Completed
Age: over 16
Sponsor: NCI
Protocol IDs: SWOG-7315/16
Phase III Combination Chemotherapy with ADR/ARA-C or PRED/VCR and Maintenance with BCG Immunotherapy for Adult Acute Leukemia
Phase: Phase III
Type: Treatment
Status: Completed
Age: 15 and over
Sponsor: NCI
Protocol IDs: SWOG-7416/17, MDAR-3
Start Over